Wells Fargo’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$581K Buy
159,591
+29,469
+23% +$107K ﹤0.01% 3679
2025
Q1
$250K Buy
130,122
+7,725
+6% +$14.8K ﹤0.01% 4106
2024
Q4
$233K Buy
122,397
+23,099
+23% +$43.9K ﹤0.01% 4220
2024
Q3
$131K Buy
99,298
+3,199
+3% +$4.22K ﹤0.01% 4468
2024
Q2
$98K Buy
96,099
+88,057
+1,095% +$89.8K ﹤0.01% 4591
2024
Q1
$14.7K Sell
8,042
-3,054
-28% -$5.59K ﹤0.01% 5267
2023
Q4
$13.8K Buy
11,096
+83
+0.8% +$103 ﹤0.01% 5304
2023
Q3
$12.6K Sell
11,013
-118
-1% -$135 ﹤0.01% 5374
2023
Q2
$10.2K Sell
11,131
-1,133
-9% -$1.04K ﹤0.01% 5592
2023
Q1
$6.87K Sell
12,264
-1,215
-9% -$681 ﹤0.01% 5648
2022
Q4
$7.78K Sell
13,479
-335
-2% -$193 ﹤0.01% 5317
2022
Q3
$4K Sell
13,814
-1,142
-8% -$331 ﹤0.01% 5624
2022
Q2
$4K Sell
14,956
-280,677
-95% -$75.1K ﹤0.01% 5763
2022
Q1
$212K Sell
295,633
-52,320
-15% -$37.5K ﹤0.01% 4643
2021
Q4
$787K Buy
347,953
+202,143
+139% +$457K ﹤0.01% 4041
2021
Q3
$421K Buy
145,810
+126,159
+642% +$364K ﹤0.01% 4484
2021
Q2
$75K Sell
19,651
-88,744
-82% -$339K ﹤0.01% 5092
2021
Q1
$367K Sell
108,395
-152,311
-58% -$516K ﹤0.01% 4554
2020
Q4
$730K Sell
260,706
-51,184
-16% -$143K ﹤0.01% 4179
2020
Q3
$782K Buy
311,890
+5,567
+2% +$14K ﹤0.01% 3946
2020
Q2
$4.16M Buy
306,323
+63,970
+26% +$869K ﹤0.01% 2609
2020
Q1
$1.84M Buy
242,353
+40,510
+20% +$307K ﹤0.01% 3013
2019
Q4
$1.28M Sell
201,843
-1,944
-1% -$12.3K ﹤0.01% 3640
2019
Q3
$798K Buy
203,787
+34,392
+20% +$135K ﹤0.01% 3940
2019
Q2
$820K Buy
169,395
+20,566
+14% +$99.6K ﹤0.01% 3943
2019
Q1
$1.22M Sell
148,829
-9,781
-6% -$80K ﹤0.01% 3695
2018
Q4
$878K Buy
158,610
+79,973
+102% +$443K ﹤0.01% 3846
2018
Q3
$694K Sell
78,637
-41,048
-34% -$362K ﹤0.01% 4136
2018
Q2
$1.19M Buy
119,685
+5,507
+5% +$54.9K ﹤0.01% 3814
2018
Q1
$1.09M Sell
114,178
-7,034
-6% -$67K ﹤0.01% 3790
2017
Q4
$1.8M Buy
121,212
+32,024
+36% +$476K ﹤0.01% 3405
2017
Q3
$1.75M Buy
89,188
+1,072
+1% +$21.1K ﹤0.01% 3366
2017
Q2
$1.27M Buy
88,116
+880
+1% +$12.6K ﹤0.01% 3491
2017
Q1
$802K Sell
87,236
-1,811
-2% -$16.6K ﹤0.01% 3839
2016
Q4
$926K Buy
89,047
+4,972
+6% +$51.7K ﹤0.01% 3688
2016
Q3
$761K Buy
84,075
+952
+1% +$8.62K ﹤0.01% 3604
2016
Q2
$621K Sell
83,123
-3,934
-5% -$29.4K ﹤0.01% 3700
2016
Q1
$784K Sell
87,057
-5,094
-6% -$45.9K ﹤0.01% 3506
2015
Q4
$1.19M Buy
92,151
+78,841
+592% +$1.02M ﹤0.01% 3302
2015
Q3
$128K Buy
13,310
+5,189
+64% +$49.9K ﹤0.01% 4555
2015
Q2
$84K Buy
8,121
+8
+0.1% +$83 ﹤0.01% 4983
2015
Q1
$91K Buy
8,113
+1,150
+17% +$12.9K ﹤0.01% 4618
2014
Q4
$80K Buy
6,963
+5,653
+432% +$64.9K ﹤0.01% 4665
2014
Q3
$29K Sell
1,310
-2,147
-62% -$47.5K ﹤0.01% 4989
2014
Q2
$96K Buy
+3,457
New +$96K ﹤0.01% 4591